| ASSET | YEAR | % RETURN |
|---|---|---|
Xpeng (XPEV) | 2025 | 105.1% |
Alibaba (BABA) | 2025 | 67.2% |
Intracellular Th (ITCI) | 2025 | 55.96% |
Banco Bilbao Viscaya Argentaria SA ADR (BBVA) | 2025 | 51.75% |
Banco Santander SA ADR (SAN) | 2025 | 51.45% |
Futu (FUTU) | 2025 | 50.57% |
CVS Health (CVS) | 2025 | 47.45% |
Gold Fields Ltd ADR (GFI) | 2025 | 46.34% |
BeiGene (ONC) | 2025 | 42.02% |
Deutsche Bank (DB) | 2025 | 40.81% |
Okta (OKTA) | 2025 | 40.69% |
Elbit Systems (ESLT) | 2025 | 40.05% |
ArcelorMittal SA ADR (MT) | 2025 | 39.36% |
AngloGold Ashanti (AU) | 2025 | 38.83% |
Bancolombia SA ADR (CIB) | 2025 | 36.2% |
Super Micro Computer (SMCI) | 2025 | 36.16% |
Lloyds Banking Group PLC ADR (LYG) | 2025 | 35.93% |
Alamos Gold (AGI) | 2025 | 34.49% |
Ke Holdings (BEKE) | 2025 | 34.01% |
ING Group NV ADR (ING) | 2025 | 31.45% |
Rocket Companies (RKT) | 2025 | 31.24% |
Agnico Eagle Mines (AEM) | 2025 | 31.03% |
Itau Unibanco Banco (ITUB) | 2025 | 30.29% |
Royalty Pharma (RPRX) | 2025 | 29.11% |
Franco-Nevada (FNV) | 2025 | 29.04% |
Large-cap stocks are treated as having a market cap of $10B+.
